A comprehensive view of AmerisourceBergen Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Study finds US drug distribution industry expands as COVID-19 disruption fades and biosimilars boom; combined revenue at AmerisourceBergen, Cardinal Health, McKesson projected to reach US$616.0B in 2022: Drug Channels Institute

AmerisourceBergen acquiring German life sciences services firm PharmaLex Holding for €1.28 billion; deal to enhance AmerisourceBergen’s European presence in pharmaceutical distribution, biopharma manufacturer services capabilities

AmerisourceBergen signs US$19.8M deal with HHS to distribute up to 2,500 shipments per week of Bavarian Nordic’s Jynneos vaccine and Siga’s TYPOXX to treat monkeypox; Jynneos is shipped frozen, TYPOXX is shipped at ambient temperature

Eli Lilly’s COVID-19 drug bebtelovimab commercially available in US from distributor AmerisourceBergen to states, hospitals, healthcare providers; drug authorized for emergency use to treat mild-to-moderate COVID-19 in adults, high-risk kids 12 or older

AmerisourceBergen reports fiscal year 2022 Q3 GAAP net income up at US$407.0M from US$292.1M a year ago, with revenue up 12.5% year-over-year to US$60.1B; growth driven by 120.3% increase in International Healthcare Solutions revenue

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count